Ryan Walker represents both issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, secondary and follow-on offerings and investment grade and high yield debt offerings. Ryan also represents both issuers and underwriters in special purpose acquisition companies (“SPACs”), and regularly advises companies with respect to SEC reporting obligations, corporate governance and other corporate and securities law matters.

Download full bio 


  • Oyster Point Pharma to Be Acquired by Viatris 

  • Scholar Rock – $205 Million Registered Direct Offering 

  • argenx – $805 Million Follow-On Offering 

  • Elevation Oncology – $107 Million IPO 


  • Georgetown University Law Center
    JD, 2019

  • Rutgers, The State University of New Jersey
    BA, Political Science
    summa cum laude, 2015

Admissions & Credentials

New York

Media & Insight